Purinethol
Acute Lymphocytic Leukaemia
50mg
Mercaptopurine tablets for acute lymphoblastic leukaemia. They interfere with the DNA building blocks in cancer cells.
From$0.70/ tabletView
Mercaptopurine
Mercaptopurine (Purinethol) is a cancer medicine used in the treatment of acute lymphocytic leukaemia. This page covers the one formulation available in the catalogue.
Key points
- Antimetabolite medicine: Mercaptopurine is a purine analogue that interferes with DNA and RNA production in rapidly dividing cells.
- Tablet only: The single formulation is a 50 mg oral tablet. No other dosage form is listed.
- Originator: Purinethol was originally developed by GlaxoSmithKline and is the only brand in this catalogue.
How Mercaptopurine works
Mercaptopurine is converted by the body into active compounds that interfere with DNA production in cells that divide rapidly, such as those found in leukaemia. Listed as a 50 mg tablet, it is the only formulation in this catalogue and was originally developed by GlaxoSmithKline.